MedPath

octurnal nutritional supplementation in advanced liver disease - a randomised trial

Phase 2
Completed
Conditions
iver cirrhosis
Liver cirrhosis
Other - Liver
Registration Number
ACTRN12605000450617
Lead Sponsor
Dr Lindsay Plank
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
110
Inclusion Criteria

Patients with chronic liver disease referred for nutritional support who have cirrhosis of the liver. Written informed consent.

Exclusion Criteria

Unable or unwilling to take the food supplement as prescribed; on waiting list for liver transplantation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total body protein change from baseline to 6 months.[Measured at baseline and 6 months]
Secondary Outcome Measures
NameTimeMethod
Fatigue score[Measured at baseline, 3, 6 and 12 months.];Physiologic function[Measured at baseline, 3, 6 and 12 months.];Health-related quality of life[Measured at baseline, 3, 6 and 12 months.];GH/IGF axis[Measured at baseline, 3, 6 and 12 months.]
© Copyright 2025. All Rights Reserved by MedPath